NCT02422654View on ClinicalTrials.gov

Taste Evaluation of Different Liquid Formulations With Eliglustat

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Gaucher Disease
Interventions
DRUG

eliglustat

"Pharmaceutical form:liquid formulation~Route of administration: oral without ingestion"

Trial Locations (1)

47710

Investigational Site Number 840001, Evansville

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT02422654 - Taste Evaluation of Different Liquid Formulations With Eliglustat | Biotech Hunter | Biotech Hunter